← Browse by Condition
Medical Condition

hemorrhage

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hemorrhage Clinical Trials

How many clinical trials are currently recruiting for hemorrhage?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hemorrhage?
hemorrhage research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hemorrhage clinical trial?
Eligibility criteria for hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
University Medical Center Groningen 1 trial
University of Arizona 1 trial
Patel Hospital, Pakistan 1 trial
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial

Recruiting Clinical Trials

NCT04615065
Recruiting
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Enrollment
35,000 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT02972385
Recruiting
Pharmacogenomics of Warfarin in Hispanics and Latinos
Enrollment
400 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT07098780 Phase 4
Recruiting
Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery
Enrollment
140 pts
Location
Pakistan
Sponsor
Patel Hospital, Pakistan
View Trial →
NCT06263075
Recruiting
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
Enrollment
30 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →

Related Conditions

thrombosis (2) acute disease (1) sepsis (1) pneumonia (1) frailty (1) complication of treatment (1) pulmonary embolism (1) acute kidney injury (1) electrolyte disturbance (1) shock (1) polypharmacy (1) intoxication by drug (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology